Ovation iX Iliac Stent Graft Iliac Limb (REF TV-IL1414160-J)Recalls & reported problems
Endologix LLC · The TriVascular® Ovation Prime® Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft is an endovascular device delivered via a small diameter catheter to treat abdominal aortic aneurysms (AAAs). The stent graft is designed to reline the diseased vasculature, providing an endovascular blood conduit for isolating the aneurysm from the high pressure flow of blood, thereby reducing the risk of rupture. The stent graft is a modular configuration comprised of an aortic body section, iliac limbs, and iliac extensions as required. The TriVascular Ovation Prime Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft includes, an Aortic Body Stent Graft and delivery catheter, Iliac Limb Stent Grafts and delivery catheters, Iliac Extension Stent Grafts and delivery catheters, as required, a Fill Polymer Kit, and an Autoinjector. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 7
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI M701TVIL1414160J1), received between Sep 27, 2016 and Dec 20, 2023 — classified as 7 injuries.
The most frequently reported specific device problem is “Complete Blockage” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Complete Blockage2
- Adverse Event Without Identified Device or Use Problem1
- Insufficient Device Problem Information1
- Lack of Effect1
- Obstruction of Flow1
- Occlusion Within Device1
- Off-Label Use1
Patient problems
- Occlusion4
- Failure of Implant3
- Aneurysm1
- Clinical Endoleak1
- Pain1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryDec 20, 2023Off-Label Use; Lack of Effect; Off-Label Use; Lack of Effect
THE PATIENT WAS IMPLANTED WITH THE OVATION IX STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY FOUR (4) YEARS POST INITIAL PROCEDURE, A TYPE 1B ENDOLEAK WAS IDENTIFIED. THE PHYSICIAN ELECTED TO COIL THE RIGHT INTERNAL ILIAC ARTERY AND PLACE TWO OVATION ILIAC LIMB EXTENSIONS INTO THE RIGHT EXTERNAL ILIAC ARTERY. THE ENDOLEAK WAS SUCCESSFULLY RESOLVED. THE PATIENT DID WELL AND WAS DISCHARGED HOME.
Patient problems: Clinical Endoleak
MAUDE report 18369277 ↗InjuryApr 5, 2021Complete Blockage; Complete Blockage
THE PATIENT WAS INITIALLY IMPLANTED WITH AN ALTO STENT GRAFT MAIN BODY AND TWO (2) OVATION IX LIMB EXTENSIONS TO TREAT AN ABDOMINAL AORTIC ANEURYSM. APPROXIMATELY, FIVE (5) MONTHS POST INITIAL IMPLANT, OCCLUSION WITH LIMB COMPRESSION WAS IDENTIFIED ON THE OVATION IX LEFT LIMB LIKELY DUE TO THROMBOSIS. THE PATIENT HAS DECLINED TREATMENT AND WAS REPORTED AS DOING WELL. THE PATIENT WILL BE MONITORED. ADDITIONAL INFORMATION: SUBSEQUENT TO THE INITIAL REPORT, CLINICAL ASSESSMENT IDENTIFIED EVIDENCE OF A TYPE II (NON-DEVICE RELATED) ENDOLEAK FROM INFERIOR MESENTERIC ARTERY.
Patient problems: Failure of Implant
MAUDE report 11615964 ↗InjuryDec 16, 2020Complete Blockage; Complete Blockage
THE PATIENT WAS INITIALLY IMPLANTED WITH AN OVATION IX STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY TWO (2) MONTHS POST INITIAL PROCEDURE THERE WAS AN OCCLUDED LEFT LIMB AND CROSS LIMBS WERE IDENTIFIED. A SECONDARY PROCEDURE WAS PERFORMED. THE PHYSICIAN PERFORMED AN OPEN THROMBECTOMY THEN PLACED STENTS AND AN OVATION ILIAC LIMB EXTENSION TO COVER THE CLOT. THE PATIENT WAS REPORTED AS DOING FINE POST SECONDARY PROCEDURE.
Patient problems: Occlusion
MAUDE report 11024076 ↗InjuryNov 21, 2019Insufficient Device Problem Information; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY IMPLANTED WITH THE OVATION IX ABDOMINAL AORTIC STENT GRAFT SYSTEM. APPROXIMATELY FOUR (4) MONTHS POST-OP, THE PATIENT PRESENTED EMERGENTLY WITH A COMPLAINT OF LEG PAIN. A RIGHT LIMB AND RIGHT FEMORAL OCCLUSION WERE DETECTED WITH POSSIBLE PROXIMAL MIGRATION OF THE LIMB. A DECISION WAS MADE TO TREAT THE PATIENT WITH A 14X100 OVATION IX ILIAC LIMB AND THROMBECTOMY WHICH SUCCESSFULLY RESOLVED THE OCCLUSION. THE PATIENT WAS DISCHARGED POST-OP DAY 2. THE PATIENT IS REPORTED AS DOING WELL AND HEALTHY AND WILL CONTINUE TO BE MONITORED.
Patient problems: Occlusion; Pain
MAUDE report 9359178 ↗InjuryDec 19, 2018Obstruction of Flow; Obstruction of Flow
THE PATIENT WAS INITIALLY TREATED WITH THE OVATION IX ABDOMINAL AORTIC ANEURYSM STENT. APPROXIMATELY NINE (9) MONTHS POST INITIAL PROCEDURE IN (B)(6) 2018, A LIMB OCCLUSION WAS DETECTED. THE PHYSICIAN PLANS TO RELINE WITH AN OVATION DEVICE AND WILL CONTINUE TO MONITOR THE PATIENT. THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Failure of Implant; Occlusion
MAUDE report 8178626 ↗InjuryDec 18, 2017Occlusion Within Device; Occlusion Within Device
AN OVATION IX ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE PATIENT RETURNED APPROXIMATELY ONE YEAR POST INDEX PROCEDURE WITH AN OCCLUDED RIGHT LIMB. PHYSICIAN HAS ELECTED TO RE-INTERVENE AT A LATER DATE BY PLACING A WIRE INTO THE LIMB AND BALLOONING/STENTING AS NECESSARY TO RESTORE FLOW TO THE LIMB. AS OF THE DATE OF THIS REPORT THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Failure of Implant; Occlusion
MAUDE report 7125697 ↗InjurySep 27, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AN AFX STENT GRAFT SYSTEM WITH OVATION IX ILIAC LIMBS WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE FINAL ANGIOGRAM SHOWED THE PRESENCE OF A TYPE IIIA ENDOLEAK AT THE OVERLAP OF THE AFX MAIN BODY AND THE OVATION IX ILIAC LIMB STENT GRAFT. A RE-INTERVENTION WAS PERFORMED TO PLACE A BALLOON EXPANDABLE STENT AND AN ADDITIONAL AFX STENT GRAFT TO RE-LINE THE STENT GRAFT SUCCESSFULLY RESOLVING THE ENDOLEAK. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Aneurysm
MAUDE report 5980708 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page